Anti-depressants and centrally active agents for fibromyalgia syndrome

María Betina Nishishinya; B. Walitt; G. Urrutia; P. Mease; A. Rodriguez; R. Riera; L. Gonzalez; G. Darko

doi:10.1002/14651858.CD006192

Anti-depressants and centrally active agents for fibromyalgia syndrome

María Betina Nishishinya
, B. Walitt
, G. Urrutia
, P. Mease
, A. Rodriguez
, R. Riera
, L. Gonzalez
, G. Darko

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: The objective is to assess the efficacy and safety of anti-depressants and centrally active agents in the treatment of fibromyalgia syndrome.

Original language	English
Article number	CD006192
Journal	Cochrane Database of Systematic Reviews
Issue number	4
DOIs	https://doi.org/10.1002/14651858.CD006192
State	Published - 2006

Access to Document

10.1002/14651858.CD006192

Cite this

@article{b53e9330467c409292863ddc57910f54,

title = "Anti-depressants and centrally active agents for fibromyalgia syndrome",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: The objective is to assess the efficacy and safety of anti-depressants and centrally active agents in the treatment of fibromyalgia syndrome.",

author = "Nishishinya, \{Mar{\'i}a Betina\} and B. Walitt and G. Urrutia and P. Mease and A. Rodriguez and R. Riera and L. Gonzalez and G. Darko",

year = "2006",

doi = "10.1002/14651858.CD006192",

language = "English",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Anti-depressants and centrally active agents for fibromyalgia syndrome

AU - Nishishinya, María Betina

AU - Walitt, B.

AU - Urrutia, G.

AU - Mease, P.

AU - Rodriguez, A.

AU - Riera, R.

AU - Gonzalez, L.

AU - Darko, G.

PY - 2006

Y1 - 2006

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: The objective is to assess the efficacy and safety of anti-depressants and centrally active agents in the treatment of fibromyalgia syndrome.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: The objective is to assess the efficacy and safety of anti-depressants and centrally active agents in the treatment of fibromyalgia syndrome.

UR - https://www.scopus.com/pages/publications/37649029802

U2 - 10.1002/14651858.CD006192

DO - 10.1002/14651858.CD006192

M3 - Review article

AN - SCOPUS:37649029802

SN - 1469-493X

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

M1 - CD006192

ER -

Anti-depressants and centrally active agents for fibromyalgia syndrome

Abstract

Access to Document

Other files and links

Fingerprint

Cite this